Not only providing common CRO services, IBERICA supports and collaborates with Academia. By utilizing clinical pharmacology units both in Japan and the US, IBERICA supports various clinical studies aiming at the development in Japan and overseas.
Under the Commercial ARO platform which is the only one in Japan, IBERICA realizes the conduct of pharmacology studies or POC studies with state-of-the-art technology. IBERICA also supports global development strategies in the early clinical phase such as a simultaneous PK/PD studies in Japan and the US, or Japanese-studies in the US.
Not just providing a series of full services involved in the clinical development, IBERICA always provides services which can meet the latest R&D trends in the life science field, making contribution to the advancement of life science.
Not only providing overall CRO services in the life science field, IBERICA provides strong supports health science companies, by utilizing the strategic collaboration with Academia and other companies, proposing innovative methods for R&D of pharmaceutical products, medical devices and healthy food.
Provide innovative solutions by integrating Academia and companies